Search - tctmd.com

$TCT-50. Influence of Age on Clinical Outcomes in Patients with NSTEMI Undergoing Treatment with Abciximab plus Unfractionated Heparin vs. Bivalirudin: Analysis of the ISAR...$

Presentation TCT 2012

TCT-50. Influence of Age on Clinical Outcomes in Patients with NSTEMI Undergoing Treatment with Abciximab plus Unfractionated Heparin vs. Bivalirudin: Analysis of the ISAR...

Presenter: Lamin King

October 23, 2012

News Daily News

Bivalirudin Lowers Bleeding in NSTEMI Patients Undergoing PCI

Jason Kahn

October 19, 2012

News Daily News

CathPCI Registry Report Details Contemporary US Practice Patterns

Caitlin E. Cox

October 18, 2012

News Daily News

In Transradial PCI, Bivalirudin Fails to Budge Event Rates vs. Heparin

October 12, 2012

News Daily News

HORIZONS-AMI: Similar Outcomes with Abciximab, Eptifibatide During Primary PCI

July 05, 2012

News Daily News

Rates of Silent Stroke Similar for Radial, Femoral Cath in Aortic Disease Patients

Yael L. Maxwell

June 27, 2012

News Daily News

Antithrombotic Choice During PCI Influences Outcomes in Poor Clopidogrel Responders

Caitlin E. Cox

June 07, 2012

News Daily News

Provisional Heparin Feasible for Preventing Occlusion in Transradial Catheterization

April 30, 2012

$Unfractionated, Low Molecular Weight Heparins, and Xa Inhibitors in ACS and PCI, With and Without GP IIb/IIIa Inhibitors$

Presentation Fellows 2012

Unfractionated, Low Molecular Weight Heparins, and Xa Inhibitors in ACS and PCI, With and Without GP IIb/IIIa Inhibitors

Presenter: George Dangas

April 22, 2012

News Daily News

PRODIGY Published: No Advantage to Long-term Clopidogrel

April 03, 2012

News Daily News

IABP Use Most Risky in ACS Patients Undergoing Urgent PCI

March 22, 2012

News Daily News

In-Hospital Bleeding, Mortality Linked Long After NSTEMI

Caitlin E. Cox

March 12, 2012

Advertisement

La Bivalirudina Mejora a la Heprina en la Reducción del Riesgo Hemorrágico tras la CAS

Bivalirudin Bests Heparin for Lowering Bleeding Risk After CAS

Radial, Femoral PCI Show Similar Bleeding Rates in NSTE ACS Patients

Meta-Analysis Finds No Clear Answer for Same-Day Discharge After PCI

Prasugrel, Ticagrelor Show Delayed Action in STEMI Patients

Bivalirudin Shows Advantage Over GPIs—But Not Heparin Alone—in STEMI Patients

Procedural, Spontaneous MI Carry Different Prognostic Weights

Debate: Enoxaparin or Unfractionated Heparin Plus/Minus Glycoprotein IIb/IIIa Inhibitors Is the Preferred Anticoagulant Strategy During STEMI!

TCT-50. Influence of Age on Clinical Outcomes in Patients with NSTEMI Undergoing Treatment with Abciximab plus Unfractionated Heparin vs. Bivalirudin: Analysis of the ISAR...

Bivalirudin Lowers Bleeding in NSTEMI Patients Undergoing PCI

CathPCI Registry Report Details Contemporary US Practice Patterns

In Transradial PCI, Bivalirudin Fails to Budge Event Rates vs. Heparin

HORIZONS-AMI: Similar Outcomes with Abciximab, Eptifibatide During Primary PCI

Rates of Silent Stroke Similar for Radial, Femoral Cath in Aortic Disease Patients

Antithrombotic Choice During PCI Influences Outcomes in Poor Clopidogrel Responders

Provisional Heparin Feasible for Preventing Occlusion in Transradial Catheterization

Unfractionated, Low Molecular Weight Heparins, and Xa Inhibitors in ACS and PCI, With and Without GP IIb/IIIa Inhibitors

PRODIGY Published: No Advantage to Long-term Clopidogrel

IABP Use Most Risky in ACS Patients Undergoing Urgent PCI

In-Hospital Bleeding, Mortality Linked Long After NSTEMI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content